Recent Analysts’ Ratings Updates for Transcat (TRNS)

Several brokerages have updated their recommendations and price targets on shares of Transcat (NASDAQ: TRNS) in the last few weeks:

• 10/30/2024 – Transcat had its “outperform” rating reaffirmed by analysts at Oppenheimer Holdings Inc.. They now have a $130.00 price target on the stock, down previously from $155.00.
• 10/30/2024 – Transcat had its price target lowered by analysts at Northland Securities from $130.00 to $110.00. They now have a “market perform” rating on the stock.
• 10/30/2024 – Transcat had its price target lowered by analysts at Craig Hallum from $138.00 to $113.00. They now have a “buy” rating on the stock.
• 10/29/2024 – Transcat was downgraded by analysts at StockNews.com from a “hold” rating to a “sell” rating.
• 10/29/2024 – Transcat had its “buy” rating reaffirmed by analysts at HC Wainwright. They now have a $156.00 price target on the stock.

Transcat Price Performance

Shares of TRNS traded up $0.83 during trading hours on Tuesday, hitting $103.39. The stock had a trading volume of 19,769 shares, compared to its average volume of 55,020. The firm has a 50 day simple moving average of $117.89 and a 200-day simple moving average of $121.78. The firm has a market capitalization of $951.19 million, a P/E ratio of 52.22 and a beta of 0.69. Transcat, Inc. has a 1-year low of $92.00 and a 1-year high of $147.12.

Transcat (NASDAQ:TRNS) last issued its earnings results on Monday, October 28th. The scientific and technical instruments company reported $0.35 earnings per share (EPS) for the quarter, missing analysts’ consensus estimates of $0.47 by ($0.12). Transcat had a net margin of 6.63% and a return on equity of 7.36%. The business had revenue of $67.83 million for the quarter, compared to the consensus estimate of $70.30 million. During the same period in the previous year, the firm earned $0.41 EPS. The company’s revenue was up 8.0% compared to the same quarter last year. Equities analysts predict that Transcat, Inc. will post 1.76 EPS for the current fiscal year.

Institutional Inflows and Outflows

Hedge funds have recently made changes to their positions in the company. Quadrature Capital Ltd purchased a new position in shares of Transcat during the 1st quarter valued at $619,000. Conestoga Capital Advisors LLC grew its position in shares of Transcat by 17.9% during the 3rd quarter. Conestoga Capital Advisors LLC now owns 907,191 shares of the scientific and technical instruments company’s stock valued at $109,561,000 after purchasing an additional 137,830 shares in the last quarter. Calamos Advisors LLC grew its position in shares of Transcat by 76.0% during the 2nd quarter. Calamos Advisors LLC now owns 15,441 shares of the scientific and technical instruments company’s stock valued at $1,848,000 after purchasing an additional 6,667 shares in the last quarter. First Horizon Advisors Inc. grew its position in shares of Transcat by 26.4% during the 2nd quarter. First Horizon Advisors Inc. now owns 599 shares of the scientific and technical instruments company’s stock valued at $72,000 after purchasing an additional 125 shares in the last quarter. Finally, Raymond James & Associates grew its position in shares of Transcat by 157.2% during the 3rd quarter. Raymond James & Associates now owns 20,651 shares of the scientific and technical instruments company’s stock valued at $2,494,000 after purchasing an additional 12,622 shares in the last quarter. 98.34% of the stock is currently owned by hedge funds and other institutional investors.

Transcat, Inc provides calibration and laboratory instrument services in the United States, Canada, and internationally. It operates through two segments: Service and Distribution. The Service segment offers calibration, repair, inspection, analytical qualification, preventative maintenance, consulting, and other related services.